TrialJournal of neuro-oncology2011

Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma.

David A Reardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.